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We assessed the association between several cardiometabolic risk factors (CRFs) (blood pressure, LDL-cholesterol, HDL-
cholesterol, triglycerides, uric acid, and glucose) in 390 young adults aged 19-20 years in Seychelles (Indian Ocean, Africa) and
body mass index (BMI) measured either at the same time (cross-sectional analysis) or at the age of 12–15 years (longitudinal
analysis). BMI tracked markedly between age of 12–15 and age of 19-20. BMI was strongly associated with all considered CRFs
in both cross-sectional and longitudinal analyses, with some exceptions. Comparing overweight participants with those having a
BMI below the age-specificmedian, the odds ratios for high blood pressure were 5.4/4.7 (male/female) cross-sectionally and 2.5/3.9
longitudinally (𝑃 < 0.05). Significant associations were also found for most other CRFs, with some exceptions. In linear regression
analysis including both BMI at age of 12–15 and BMI at age of 19-20, only BMI at age of 19-20 remained significantly associated
withmost CRFs.We conclude that CRFs are predicted strongly by either current or past BMI levels in adolescents and young adults
in this population. The observation that only current BMI remained associated with CRFs when including past and current levels
together suggests that weight control at a later age may be effective in reducing CRFs in overweight children irrespective of past
weight status.
1. Introduction
Obesity is known to be associated with cardiovascular
outcomes [1–3] and with elevated levels of several car-
diometabolic risk factors (CRFs), including blood pressure
and several metabolic factors [4]. The association between
obesity and several CRFs has already been observed in
children and adolescents both cross-sectionally [5–7] and
longitudinally [8–10], but the data are limited. Furthermore,
intervention studies through lifestyle interventions [11], and
bariatric surgery [12] in children show that a reduction of
body weight among obese children results in reduced levels
of several CRFs, such as blood pressure [13–15], lipids [16–
18], and insulin [19]. There are several methods to measure
adiposity in children, including BMI, waist circumference, or
the waist-to-hip ratio. There is continued debate on which
indicator best predicts cardiovascular risk [20] but several
studies suggest that body mass index (BMI) can adequately
predict cardiovascular risk in adults, adolescents, and young
adults [9, 21, 22].
There is, however, a relative scarcity of studies that
have examined the relation between obesity and CRFs in
population-based samples of children and adolescents (i.e.,
outside of the clinical setting). Furthermore, most such
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studies in children and adolescents have relied on a cross-
sectional design, although a few did have a prospective
design, butmost such studies were conducted in high-income
countries [8, 9]. Furthermore, only a few studies have simul-
taneously compared the relative strength of the associations
between obesity and a broad set of CRFs including both
physiological risk factors (e.g., blood pressure) and biological
markers (e.g., blood lipids, glucose, and uric acid) in youths
so that the associations between obesity and different CRFs
can be directly compared.
In this study, we examined both the cross-sectional and
longitudinal relationships between overweight and several
CRFs in a population-based sample of adolescents and young
adults. Data on CRFs were derived from a cohort study of
children followed since their birth to examine the association
between maternal fish consumption and the children’s neu-
rological development [23, 24]. In this cohort study, BMI and
CRFs were measured for the first time on the seventh follow-
up visit at the age of 19-20 years.We then linked the CRF data
with BMI valuesmeasured at the age of 12–15 years previously
obtained during a routine screening program in all schools
of the country [25, 26]. The main objectives of the present
study were to directly compare the associations between
obesity and several CRFs, to compare the associations based
on cross-sectional or longitudinal designs, and to examine
the contribution of current and past weight statuses in the
prediction of current CRF levels.
2. Methods
2.1. Study Population. The Republic of Seychelles is a rapidly
developing small island state in the Indian Ocean located
east of Kenya. The population is mostly of African descent.
Between February 1989 and February 1990, a cohort of 779
children was enrolled at the age of 6 months as part of
the Seychelles Child Development Study (SCDS). Details of
this cohort study have been previously described [24]. The
SCDS was undertaken to assess the association between pre-
natal exposure to methyl mercury from fish consumption
and neurocognitive development in a sample of children
representative of the general population. BMI and a broad
set of cardiometabolic risk factors were measured for the first
time in the seventh follow-up visit in 2008-2009 when the
participantswere aged 19-20 years (age range: 18.7–20.5;mean
age: 19.5; SD: 0.5).
2.2. Linkage of Data. BMI at the age of 12–15 years was
derived from a routine school-based surveillance program.
BMI was measured when children were in the 7th and 10th
grades and were aged approximately 12.7 years for children
in the 7th grade (SD: 0.4; range: 11.6–13.4) and 13.9 years
for children in the 10th grade (SD: 0.6; range: 12.1–15.9). The
school screening program was conducted in all public and
private schools in Seychelles under the auspices of the Min-
istries of Health and Education. The methods and results of
this screening program have been published previously [25–
27]. Linkage of BMI in the school-based screening program
with CRFs measured at the age of 19-20 years within the
SCDS study was based on the national identification number
that is available for all Seychelles citizens. We had previously
linked data from the SCDS with data from the school
screening program in order to examine the relationship
between exposure to prenatal mercury (SCDS) and blood
pressure at the age of 12–15 years (school screening program)
[28]. Informed consent was obtained from the subject and
caregiver of every participant for both the SCDS and the
school screening program. The school screening program
and the SCDS were approved by the Research and Ethical
Committee of the Ministry of Health, Victoria, Seychelles.
In addition, the SCDS was approved by the Human Subjects
Review Board at the University of Rochester, Rochester, NY,
USA.
2.3. Clinical Measurements. Measurement of anthropomet-
rics at age of 12–15 years has been detailed previously [27].
Briefly, weight was measured without shoes and in light
garments by trained school nurses in the schools, during
regular school hours (8 am–2:30 pm), using electronic scales
(Seca 870, Hamburg, Germany). Height was measured with
a fixed stadiometer (Seca 208). The same weight scales and
stadiometers were available in all schools and the instruments
were regularly checked for accuracy by the screening nurses
and further checks were preformed at least once per year by
themanager of the screening program. BMI was calculated as
weight (kg) divided by height (meters) squared. We used the
average of the two values of BMI measured at ages 12 and 15
years, to reflect BMI in early adolescence.
At the age of 19-20 years, all measurements took place
between 8 a.m. and 10 a.m. at the SCDS study center. Weight
was measured with a precision electronic scale (Seca 870)
and height wasmeasured with a fixed stadiometer (Seca 208).
The instruments were regularly checked for accuracy. BP was
measured using a validated oscillometric automated device
(Omron M5). Three readings were measured by a nurse, on
the left arm, and using an appropriately sized cuff. Readings
were taken at intervals of at least 1 minute between the BP
readings after the participant had been sitting for at least 5
minutes. Systolic BP (SBP) and diastolic BP (DBP)were based
on the average of the three readings.
2.4. Biological Samples. Themethods used tomeasure venous
blood taken at the age of 19-20 years have been described pre-
viously [21]. Briefly, venous blood sampleswere collected after
an overnight fast. Glucose, total cholesterol,HDL-cholesterol,
triglycerides, and uric acid were measured at the central
laboratory of the main hospital in Seychelles (Seychelles
Hospital), using standard enzymatic methods (Konelab T
series reagents, Thermo Scientific) with a Thermo Konelab
30 automatic analyzer (KonelabCorp., Espoo, Finland). LDL-
cholesterol was calculated using the Friedewald formula.
2.5. Statistical Analyses. Among the 423 adolescents who
had complete data on CRFs and BMI at the age of 19-20
years in the SDCS (77% of 549 children seen at the age of
19-20 years), 390 (92%) also had data on BMI at the age
of 12–15 years; hence, this study includes 390 participants.
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Analyses were conducted separately in males and females
because of substantial sex differences in the distribution of
several variables, including BMI and several CRFs, and the
possibility that the relations between BMI and CRFs may
differ according to sex. In order to examine the associations
between BMI and CRFs, we considered three categories of
body weight: (1) “low” BMI was defined as a BMI below the
median values for age and sex (both at age of 19-20 years
and at age of 12–15 years); (2) “elevated” BMI was defined as
BMI above the age- and sex-specific median values of BMI
and below the age- and sex-specific BMI cut-off values for
“overweight”; and (3) “overweight.” Overweight at age of 12–
15 years was defined according to the age- and sex-specific
IOTF criteria of overweight [29]. Overweight in persons
aged 18 years and above follows guidelines in adults and are
defined as a BMI of 25 or above [30]. In both adolescents and
young adults our cut-off values for “overweight” encompass
both “overweight” and “obesity” categories. We did not
distinguish between “overweight” and “obesity” because of
an insufficient number of participants. We also conducted
analyses examining the relationship between CRFs and joint
categories of body weight at both age of 12–15 years and at
age of 19-20 years (e.g., high-high, low-low, high-low, low-
high) but the sample sizes in some categories (high-low, and
low-high) were too small for meaningful statistical inference
(results are available from the authors). We tabulated the
mean values and 95% confidence intervals of CRFs according
to these three categories of BMI separately in males and
females. In order to directly compare the magnitude of the
differences of the mean values of CRFs between these three
BMI categories, we plotted the percent changes between
values in the “elevated weight” and “overweight” categories
compared to participants with low body weight.
We also provide results in terms of odds ratios of elevated
levels of CRFs according to the three defined categories of
BMI, at age of 12–15 years or at age of 19-20 years, as deter-
mined by logistic regression. Regression models were not
adjusted for other covariates, since the aim of the study was to
examine the performance of BMI to predictCRFs.Wedefined
dichotomized categories of CRFs in youths aged 19-20 years
based on recent guidelines for subjects aged 18–21 years
[31]. However, because only 4% of subjects had triglycerides
≥1.3mmol/L, we used a lower cutoff (≥1.0mmol/L) for this
parameter which resulted in a prevalence of 12%. There is
no widely used cutoff for serum uric acid in adolescents or
young adults so we defined elevated levels as levels above
the sex-specific 80th percentile. The cut-off values for the
dichotomized categories of CRFs appear in Table 3.
We also examined the linear relationship between CRFs
and BMI (used as a continuous variable) for both the
crosssectional (BMI and CRFs measured at the age of 19-
20 years) and longitudinal (BMI measured at the age of
12–15 years and CRFs measured at the age of 19-20 years)
associations using linear regression, separately in males and
females. Analyseswere done separately formales and females.
We also examined regression analysis models that included
both BMI at the age of 12–15 years and BMI at the age of 19-
20 years to determine howwell the BMI predicted the defined
outcomes at each age (i.e., to examine the association between
CRFs and BMI at age of 19-20 years given a certain BMI at age
of 12–15 years and, inversely, the association between CRFs
and BMI at age of 12–15 years given a certain BMI at age
of 19-20 years). To permit a direct comparison of the results
based on cross-sectional and longitudinal analyses, we used
standardized regression coefficients, which express change
in the considered outcomes associated with a 1 standard
deviation change in the exposure (BMI). Analyses were
performed using Stata 11.2. All analyses were done among the
390 children who had complete data at age of 12–15 years and
at age of 19-20 years. We used two-sided tests and considered
statistical significance as 𝑃 < 0.05.
3. Results
Table 1 presents the mean values and standard deviations
of BMI and CRFs as well as the prevalence of the defined
categories of BMI in participants aged 12–15 years and aged
19-20 years, separately in males and females. The proportion
of participants whowere overweight in the school evaluations
was 18.9% among males and 19.5% among females aged 12–
15 years. At age of 19-20 years, 12.6% of males and 27.9% of
females were overweight (this also includes obesity). BMI
and several CRFs differed substantially between males and
females at both the age of 12–15 years and at the age of 19-
20 years.The Spearman correlation coefficients between BMI
at age of 12–15 years and BMI at age 19-20 years were 0.69
(𝑃 < 0.001) in males and 0.83 (𝑃 < 0.001) in females, which
suggests a high degree of tracking of BMI over age.
The distribution of the CRFs at the age of 19-20 years
according to our three defined BMI categories at the age
of 12–15 years and at the age of 19-20 years is presented in
Table 2. A significant positive linear trendwas found between
categories of BMI and most CRFs at both ages. Associations
did not reach statistical significance for triglycerides and
glucose in males and LDL-cholesterol, HDL-cholesterol and
triglycerides in females at age of 12–15 years and glucose in
males at age 19-20 years.
Figure 1 shows the percent changes inmeanCRFs levels in
males and females comparing the categories “elevated BMI”
and “overweight” with “BMI below the median.” Overall,
these changes were quite similar whether based on the
longitudinal or cross-sectional analyses. However, the cross-
sectional associations tended to be slightly larger than the
longitudinal ones. The magnitude of the percent changes
tended to be larger for several metabolic markers than for BP.
However, the associations for the metabolic CRFs were not
always statistically significant, which is consistent with larger
variability (e.g., larger SD) for metabolic CRFs than for BP
(Table 1).
Table 3 shows the odds ratios (ORs) for the presence
of elevated CRFs in participants with elevated BMI and
with overweight compared to participants with low BMI.
Comparing participants with overweight versus participants
with low BMI, these ORs were as high as 4.0 (95% CI: 1.5–
10.4) for LDL-cholesterol among males aged 12–15 years and
8.0 (95% CI: 2.3–28.6) for triglycerides amongmales aged 19-
20 years. Similar to the results from the stratified (Table 2)
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Table 1: Characteristics of the participants at the age of 12–15 years
and at the age of 19-20 years.
Males
(𝑛 = 175)
Females
(𝑛 = 215) P value
Age 12–15 years
Mean age 13.88 (0.62) 13.89 (0.53)
Age range 12.01–15.98 12.01–14.57
BMI (kg/m2) 19.35 (3.31) 20.29 (3.95) 0.013
Categories of BMI
Overweight 33 (18.86) 42 (19.53)
Elevated weight 43 (24.57) 77 (35.81)
Low weight 99 (56.57) 96 (44.65) 0.035
Age 19 years
Mean age 19.51 (0.33) 19.51 (0.29)
Age range 18.8–20.4 18.8–20.5
BMI (kg/m2) 21.57 (3.47) 22.71 (5.45) 0.017
Categories of BMI
Overweight 22 (12.57) 60 (27.91)
Elevated weight 62 (35.43) 51 (23.72)
Low weight 91 (52.00) 104 (48.37) <0.001
Cardiovascular risk factors
SBP (mmHg) 121.23 (10.74) 110.49 (9.75) <0.001
DBP (mmHg) 67.36 (7.80) 69.06 (7.90) 0.034
LDL-cholesterol (mmol/L) 2.44 (0.77) 2.74 (0.84) <0.001
HDL-cholesterol (mmol/L) 1.43 (0.41) 1.35 (0.39) 0.038
Triglycerides (mmol/L) 0.69 (0.28) 0.69 (0.35) 0.963
Glucose (mmol/L) 5.22 (0.58) 4.96 (0.54) <0.001
Uric acid (mmol/L) 0.35 (0.08) 0.24 (0.07) <0.001
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic
blood pressure; LDL-cholesterol: low-density lipoprotein cholesterol; HDL-
cholesterol: high-density lipoprotein.
Results are presented as mean (standard deviation) or as number (percent-
age).
and linear regression (Table 3) analyses, the magnitude of
the associations based on dichotomous categories of CRFs
(i.e., ORs for the presence of elevated CRFs versus non
elevatedCRFs) in relation toBMI categorieswas generally not
different whether the results were derived from longitudinal
analysis (BMI measured at the age of 12–15 years and CRFs
measured at the age of 19-20 years) or cross-sectional analysis
(BMI andCRFs bothmeasured at the age of 19-20 years), with
some exceptions.
Table 4 shows the standardized linear coefficients derived
from linear regression between CRFs measured at the age
of 19-20 years and BMI measured either at the age of 12–
15 years or at the age of 19-20 years, in males and females
separately. Most of the associations were highly significant
for most CRFs at both the earlier and later ages. This is
in line with what was found for stratified analysis (Table 2,
Figure 1). The associations tended to be slightly stronger
for the cross-sectional associations between BMI and CRFs
measured at 19-20 years than for the longitudinal associations
(BMI measured at the age of 12–15 years and CRFs measured
at the age of 19-20 years). Consistent with results of stratified
analysis (Table 2), no associations were found for glucose in
males (with BMI measured at any age) as well as for LDL-
cholesterol and HDL-cholesterol in females when BMI was
measured at the age of 12–15 years.
In analyses including BMI measured at both ages, only
BMI measured at the age of 19-20 years was significantly
associated with CRFs, but not BMI measured at the age of
12–15 years. The results may be sensitive to the variability
in the measurements of the exposure variable and reflect
that BMI was measured more accurately during the research
evaluation at 19-20 years (highly standardized protocol with
few observers and scales). However, the standard deviations
of BMI were not substantially different whether BMI was
measured when participants were aged 12–15 years or 19-20
years. These results suggest that current BMI matters more
than past BMI when predicting current levels of CRFs.
4. Discussion
We found that elevated levels of BP and several metabolic
risk factors measured at the age of 19-20 years are predicted
by either current BMI or BMI levels measured several years
earlier (age of 12–15 years). Furthermore, when relating CRFs
at the age of 19-20 years toboth current and past BMI
levels, only current levels were significantly associated with
CRFs. This suggests that a life course approach to weight
control is needed but that current weight status is particularly
important in order to limit impact of adiposity on CRFs.
This is the first study to examine both the cross-sectional
and longitudinal associations between obesity and a broad
panel of CRFs in a population-based sample of adolescents
and young adults in the African region.
Our findings of strong associations between obesity and
several CRFs in adolescents and young adults are consistent
with earlier studies and holds true whether analyses are
cross-sectional [5–7] or longitudinal [8–10]. The CRFs most
consistently associated with obesity in youth include high
blood pressure, dyslipidemia, hyperinsulinemia, and insulin
resistance [9, 10, 32]. What our study adds, is that a large
impact of obesity on several CRFs can be observed both
cross-sectionally and longitudinally in adolescents and young
adults in a country in the Africa region. These data provide
further useful evidence for the need to address obesity and
its impact on CRFs in youth in the African region.
The increase in mean levels of CRFs in a dose-response
manner across categories of BMI is consistent with previous
studies showing a strong association and clustering of obesity
with CRFs in young people. It is interesting to note, from
our stratified analysis (Table 2), that the relation between
BMI and mean levels CRFs seemed to be linear (i.e., an
effect was also seenwith the intermediate “elevated” category)
in the case of BP, while the impact of BMI on several
metabolic CRFs was most apparent only in the highest BMI
category (i.e., overweight, which also includes obesity). An
implication of these findings is that interventions targeting
the entire population are useful for blood pressure control at
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Table 3: Odds ratios for the association between cardiometabolic risk factors at the age of 19-20 years and body mass index categories
measured at the age of 12–15 years or at the age of 19 years.
12–15 years 19-20 years
Males (𝑛 = 175) Females (𝑛 = 215) Males (𝑛 = 175) Females (𝑛 = 215)
Blood pressure ≥120/80mmHg (M: 53.1%; F: 21.9%)
Low BMI 1 1 1 1
Elevated BMI 1.27 (0.62–2.61) 3.89 (1.73–8.78) 3.12 (1.59–6.13) 4.70 (1.96–11.26)
Overweight 2.54 (1.10–5.90) 3.86 (1.53–9.73) 5.44 (1.84–16.06) 4.70 (2.02–10.94)
LDL-cholesterol ≥3.0mmol/L (M: 17.7%; F: 36.3%)
Low BMI 1 1 1 1
Elevated BMI 2.11 (0.81–5.56) 1.73 (0.93–3.24) 4.17 (1.60–10.88) 1.08 (0.52–2.22)
Overweight 4.00 (1.53–10.42) 1.42 (0.66–3.04) 6.86 (2.15–21.91) 2.52 (1.30–4.86)
HDL-cholesterol <1.03mmol/L (M: 15.4%; F: 20.0%)
Low BMI 1 1 1 1
Elevated BMI 0.38 (0.14–1.03) 0.98 (0.48–2.04) 0.33 (0.13–0.84) 0.68 (0.30–1.55)
Overweight 0.27 (0.10–0.75) 2.07 (0.72–5.93) 0.33 (0.10–1.12) 0.76 (0.34–1.68)
Triglycerides ≥1.00mmol/L (M: 10.9%; F: 13.0%)
Low BMI 1 1 1 1
Elevated BMI 0.67 (0.17–2.56) 0.86 (0.31–2.38) 2.19 (0.66–7.24) 1.39 (0.37–5.16)
Overweight 1.98 (0.66–5.94) 3.05 (1.18–7.89) 8.03 (2.25–28.64) 7.00 (2.60–18.88)
Glycemia ≥5.6mmol/L (M: 24.0%; F: 8.8%)
Low BMI 1 1 1 1
Elevated BMI 0.64 (0.26–1.56) 1.27 (0.39–4.10) 0.86 (0.40–1.84) 1.02 (0.24–4.26)
Overweight 0.90 (0.36–2.24) 3.00 (0.94–9.55) 0.87 (0.29–2.62) 3.27 (1.12–9.50)
Uric acid >0.39 (M) or 0.31 (F) mmol/L (M: 18.9%; F: 20.9%)
Low BMI 1 1 1 1
Elevated BMI 1.70 (0.69–4.16) 0.90 (0.42–1.94) 1.06 (0.44–2.56) 1.18 (0.48–2.89)
Overweight 1.79 (0.68–4.71) 1.62 (0.70–3.74) 3.81 (1.37–10.59) 2.75 (1.29–5.86)
LDL-cholesterol: low-density lipoprotein cholesterol; HDL-cholesterol: high-density lipoprotein. M: males; F: females.
The prevalence of elevated CRFs in males (M) and females (F) is indicated between brackets.
Low levels of BMI refer to BMI values below the age- and sex-specific medians; overweight (which also includes obesity) is defined according to standard BMI
cut-off values; and elevated BMI refers to intermediate BMI values.
Table 4: Standardized linear regression coefficients for the associations between cardiometabolic risk factors at the age of 19-20 years and
body mass index measured at the age of 12–15 years or at the age of 19-20 years.
SBP DBP LDL-cholesterol HDL-cholesterol Triglyceride Fasting glucose Uric acid
Males
BMI at 12–15 years 0.24∗∗ 0.27∗∗∗ 0.20∗∗ −0.12 0.17∗ −0.01 0.27∗∗∗
BMI at 19 years 0.27∗∗∗ 0.34∗∗∗ 0.26∗∗∗ −0.16∗ 0.38∗∗∗ 0.05 0.33∗∗∗
BMI
12–15 adj for BMI19 0.11 0.07 0.03 −0.03 −0.18 −0.09 0.08
BMI19 adj for BMI12–15 0.19
∗ 0.28∗∗ 0.24∗ −0.14 0.51∗∗∗ 0.11 0.28∗∗
Females
BMI at 14 years 0.23∗∗ 0.31∗∗∗ 0.04 −0.05 0.14∗ 0.29∗∗∗ 0.17∗
BMI at 19 years 0.31∗∗∗ 0.36∗∗∗ 0.09 −0.17∗ 0.26∗∗∗ 0.39∗∗∗ 0.27∗∗∗
BMI
12–15 adj for BMI19 −0.1 0.01 −0.15 0.35
∗∗
−0.29∗ −0.15 −0.22
BMI19 adj for BMI12–15 0.39
∗∗ 0.35∗∗ 0.22 −0.47∗∗∗ 0.51∗∗∗ 0.52∗∗∗ 0.46∗∗∗
adj: adjusted.
∗
𝑃 < 0.05; ∗∗𝑃 < 0.01; ∗∗∗𝑃 < 0.001.
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; LDL-cholesterol: low-density lipoprotein cholesterol; HDL-cholesterol:
high-density lipoprotein.
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the population level while abnormal levels of biological CRFs
might be better addressed by targeting obese adolescents and
young adults.
The question of whether BMI or different obesity indi-
cators would perform differently in their ability to predict
CRFs is still ongoing. Based on data of participants aged
19-20 years (SCDS), we previously showed that BMI was
at least as adequate as several other adiposity markers to
predict mean levels of CRFs [21]. We found in this study
that the magnitude of the associations between overweight
and CRFs was important, with odds ratios of elevated levels
of CRFs associated with overweight being larger than 2-3
for most CRFs. These results are consistent with findings in
other studies among young people, for example, the Bogalusa
Heart Study in the USA, in which a BMI larger than the 95th
percentile was associated with odds ratios of 2.4, 4.5, 3.0, 7.1,
and 12.1 for raised diastolic BP, systolic BP, LDL-cholesterol,
triglycerides, and insulin concentration, respectively, and 3.4
for low HDL cholesterol [8]. Overweight was also related
strongly to lipid markers among children aged 6–11 years in
Qatar [7]. Of note, we found strong associations between
overweight in adolescents and young adults and virtually all
components of the metabolic syndrome. The magnitude of
the observed associations and the broad scope in terms of the
many factors involved stress the importance of weight control
programs in youth.
It is interesting to note that the association between
BMI and CRFs was almost as strong in our study when
BMI was measured 4–6 years before measuring the CRF
outcomes (longitudinal design) as when they were measured
at the same time (cross-sectional design). Analyses based
on the longitudinal design strengthen the possibility that
elevated body weight is causally associated with elevated
levels of CRFs. Confounding or reverse causation is unlikely
to account for these findings (e.g., high BP or dyslipidemia
is unlikely to be the cause of obesity). It is remarkable,
however, that the longitudinal associations between BMI and
CRFs were quite strong in comparison to the cross-sectional
associations. This reinforces the conclusion that overweight
is very likely an important issue for cardiovascular health and
that weight control needs be addressed early in life.
The finding that only BMI at age of 19-20 years remained
a strong predictor of CRFs in a regression model including
both BMI at age of 12–15 years and BMI at age of 19-20 years
suggests that current BMI is particularly important in relation
to the prediction of blood pressure andmetabolic risk factors.
Conclusions must, however, be carefully drawn on these
results in view of possiblemethodological issues, for example,
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the possibility that that BMIwasmeasuredwith less precision
at age of 12–15 years in the context of a routine screening
than at age of 19-20 years in a study with highly standardized
methods.Nonetheless, this finding (i.e. that CRFs are strongly
associated with current BMI but not with BMI measured
several years earlier when considering both weight statuses
together) implies the important role of current versus past
BMI in relation to current CRFs levels. This is welcome
news since current weight, not past weight, can possibly be
addressed through interventions. However, overweight tends
to track over age, and children who were overweight when
they were younger are largely the same children who are
overweight when they are older. This is confirmed by the
Spearman correlation coefficient of BMI at age of 12–15 years
and at age of 19-20 years. The larger importance of current
versus past weight has been emphasized in previous research.
Several longitudinal studies of both past and current weights
have shown that obesity in childhood has only limited impact
when assessing cardiovascular health in adulthood [33, 34],
but other studies have found an impact of obesity in young
people on both risk factors [9, 10] and actual CVD outcomes
[35–37] in adulthood. Overall, our findings that CRFs are
associated with current and past BMI, and that BMI tracks
over time, support a life course approach to obesity including
both population-based interventions aimed at preventing the
occurrence of overweight in the population at all ages and
individual-based interventions targeting overweight among
adolescents and young adults.
The distribution of several CRFs was markedly different
between sexes. The observation of higher uric acid blood
levels in males compared to females was expected [38] and
consistent with the uricosuric effect of estrogens in females,
which confers a protective effect on several metabolic CRFs
[39]. A higher SBP in males compared to females may be
related to males being generally taller since height is an
important determinant of BP in adolescents and young adults
[40]. We found a significant association between BMI and
glucose only in females even though males had higher blood
glucose levels than females. A possible explanation for the
observed sex differences could be the greater adiposity, in par-
ticular fat mass, in females than in males [41]. The influence
of abdominal fat, which is particularly active metabolically
[42], may not be fully captured by the measurement of BMI
[43] and might be a key determinant of some of the observed
sex differences.
Our study has several strengths, including the popul-
ation-based sample; a fairly large sample size for a study
including blood markers among healthy adolescents and
young adults; a broad panel of CRF markers considering the
study included healthy participants; analyses based on both
longitudinal and cross-sectional designs; and the presence of
a minimal number of potential confounders, comorbid con-
ditions, and related treatments at this early age.There are also
some potential limitations. Accuracy of BMI measurements
at the age of 12–15 years may be less than optimal in the
context of routine school screening programs. In addition,
although participants were asked to fast, they may not have
been all fasting when blood was collected at the age of 19-
20 years. A larger sample size would also have been useful
to assess the associations separately among overweight and
obese children and in order to generate different cohorts
with sufficient numbers of children who either gained or
lost weight between age of 12–15 and age of 19-20 and the
subsequent effects on CRFs at the age of 19-20 years.
In conclusion, we found strong associations between ado-
lescents and young adults who were overweight and several
CRFs in both cross-sectional and longitudinal analyses.These
findings indicate that a life course approach to weight control
with interventions as early as possible is warranted but that
weight control even at a later age is equally or perhaps more
efficacious in reducing cardiovascular risk. These findings
in a country of the African region extend previous similar
findings in high-income countries and highlight the adverse
consequences of obesity on CRFs in adolescents and young
adults in all regions.
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